
### [MONDO:0018236](http://purl.obolibrary.org/obo/MONDO_0018236)
**Label:** dysostosis with limb and face anomalies as a major feature

**Subclasses:** [MONDO:0015399](http://purl.obolibrary.org/obo/MONDO_0015399) (glossopalatine ankylosis), [MONDO:0017139](http://purl.obolibrary.org/obo/MONDO_0017139) (oromandibular-limb hypogenesis syndrome), [MONDO:0011154](http://purl.obolibrary.org/obo/MONDO_0011154) (acrofacial dysostosis, Palagonia type), [MONDO:0012980](http://purl.obolibrary.org/obo/MONDO_0012980) (endocrine-cerebro-osteodysplasia syndrome), [MONDO:0008465](http://purl.obolibrary.org/obo/MONDO_0008465) (Patterson-Stevenson-Fontaine syndrome), [MONDO:0018980](http://purl.obolibrary.org/obo/MONDO_0018980) (acrofacial dysostosis, Kennedy-Teebi type), [MONDO:0007943](http://purl.obolibrary.org/obo/MONDO_0007943) (Nager acrofacial dysostosis), [MONDO:0007045](http://purl.obolibrary.org/obo/MONDO_0007045) (acrofacial dysostosis, Catania type), [MONDO:0007044](http://purl.obolibrary.org/obo/MONDO_0007044) (acrodysostosis 1 with or without hormone resistance), [MONDO:0011359](http://purl.obolibrary.org/obo/MONDO_0011359) (acromelic frontonasal dysostosis), [MONDO:0015367](http://purl.obolibrary.org/obo/MONDO_0015367) (Charlie M syndrome), [MONDO:0014651](http://purl.obolibrary.org/obo/MONDO_0014651) (acrofacial dysostosis Cincinnati type), [MONDO:0018237](http://purl.obolibrary.org/obo/MONDO_0018237) (acrofacial dysostosis), [MONDO:0010570](http://purl.obolibrary.org/obo/MONDO_0010570) (craniofrontonasal syndrome), [MONDO:0008673](http://purl.obolibrary.org/obo/MONDO_0008673) (acrofacial dysostosis, Weyers type), [MONDO:0017240](http://purl.obolibrary.org/obo/MONDO_0017240) (acrodysostosis with multiple hormone resistance), [MONDO:0009402](http://purl.obolibrary.org/obo/MONDO_0009402) (hypertelorism-hypospadias-polysyndactyly syndrome), [MONDO:0008712](http://purl.obolibrary.org/obo/MONDO_0008712) (Acrocraniofacial dysostosis), [MONDO:0008714](http://purl.obolibrary.org/obo/MONDO_0008714) (acrofacial dysostosis Rodriguez type), [MONDO:0009903](http://purl.obolibrary.org/obo/MONDO_0009903) (postaxial acrofacial dysostosis), [MONDO:0008715](http://purl.obolibrary.org/obo/MONDO_0008715) (acrofrontofacionasal dysostosis), [MONDO:0010539](http://purl.obolibrary.org/obo/MONDO_0010539) (X-linked mandibulofacial dysostosis), [MONDO:0007073](http://purl.obolibrary.org/obo/MONDO_0007073) (Hypoglossia-hypodactyly syndrome), [MONDO:0012516](http://purl.obolibrary.org/obo/MONDO_0012516) (mandibulofacial dysostosis-microcephaly syndrome), [MONDO:0013822](http://purl.obolibrary.org/obo/MONDO_0013822) (acrodysostosis 2 with or without hormone resistance), 

**Mapped go classes:** [GO:0030030](http://purl.obolibrary.org/obo/GO_0030030) (cell projection organization), [GO:0015030](http://purl.obolibrary.org/obo/GO_0015030) (Cajal body), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0045762](http://purl.obolibrary.org/obo/GO_0045762) (positive regulation of adenylate cyclase activity), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0046580](http://purl.obolibrary.org/obo/GO_0046580) (negative regulation of Ras protein signal transduction), [GO:0071013](http://purl.obolibrary.org/obo/GO_0071013) (catalytic step 2 spliceosome), [GO:1990402](http://purl.obolibrary.org/obo/GO_1990402) (embryonic liver development), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0004152](http://purl.obolibrary.org/obo/GO_0004152) (dihydroorotate dehydrogenase activity), [GO:0000349](http://purl.obolibrary.org/obo/GO_0000349) (generation of catalytic spliceosome for first transesterification step), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0044205](http://purl.obolibrary.org/obo/GO_0044205) ('de novo' UMP biosynthetic process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0006207](http://purl.obolibrary.org/obo/GO_0006207) ('de novo' pyrimidine nucleobase biosynthetic process), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0048013](http://purl.obolibrary.org/obo/GO_0048013) (ephrin receptor signaling pathway), [GO:0032793](http://purl.obolibrary.org/obo/GO_0032793) (positive regulation of CREB transcription factor activity), [GO:0016627](http://purl.obolibrary.org/obo/GO_0016627) (oxidoreductase activity, acting on the CH-CH group of donors), [GO:0048812](http://purl.obolibrary.org/obo/GO_0048812) (neuron projection morphogenesis), [GO:0046875](http://purl.obolibrary.org/obo/GO_0046875) (ephrin receptor binding), [GO:0045664](http://purl.obolibrary.org/obo/GO_0045664) (regulation of neuron differentiation), [GO:0008603](http://purl.obolibrary.org/obo/GO_0008603) (cAMP-dependent protein kinase regulator activity), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0001772](http://purl.obolibrary.org/obo/GO_0001772) (immunological synapse), [GO:0000398](http://purl.obolibrary.org/obo/GO_0000398) (mRNA splicing, via spliceosome), [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0098797](http://purl.obolibrary.org/obo/GO_0098797) (plasma membrane protein complex), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0032420](http://purl.obolibrary.org/obo/GO_0032420) (stereocilium), [GO:2001222](http://purl.obolibrary.org/obo/GO_2001222) (regulation of neuron migration), [GO:0031295](http://purl.obolibrary.org/obo/GO_0031295) (T cell costimulation), [GO:0036064](http://purl.obolibrary.org/obo/GO_0036064) (ciliary basal body), [GO:0040020](http://purl.obolibrary.org/obo/GO_0040020) (regulation of meiotic nuclear division), [GO:0006397](http://purl.obolibrary.org/obo/GO_0006397) (mRNA processing), [GO:0048666](http://purl.obolibrary.org/obo/GO_0048666) (neuron development), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001932](http://purl.obolibrary.org/obo/GO_0001932) (regulation of protein phosphorylation), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0008140](http://purl.obolibrary.org/obo/GO_0008140) (cAMP response element binding protein binding), [GO:0008380](http://purl.obolibrary.org/obo/GO_0008380) (RNA splicing), [GO:0060322](http://purl.obolibrary.org/obo/GO_0060322) (head development), [GO:0010181](http://purl.obolibrary.org/obo/GO_0010181) (FMN binding), [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding), [GO:0016607](http://purl.obolibrary.org/obo/GO_0016607) (nuclear speck), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0048039](http://purl.obolibrary.org/obo/GO_0048039) (ubiquinone binding), [GO:0005952](http://purl.obolibrary.org/obo/GO_0005952) (cAMP-dependent protein kinase complex), [GO:0004862](http://purl.obolibrary.org/obo/GO_0004862) (cAMP-dependent protein kinase inhibitor activity), [GO:0030623](http://purl.obolibrary.org/obo/GO_0030623) (U5 snRNA binding), [GO:0051321](http://purl.obolibrary.org/obo/GO_0051321) (meiotic cell cycle), [GO:0003404](http://purl.obolibrary.org/obo/GO_0003404) (optic vesicle morphogenesis), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0046540](http://purl.obolibrary.org/obo/GO_0046540) (U4/U6 x U5 tri-snRNP complex), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0060170](http://purl.obolibrary.org/obo/GO_0060170) (ciliary membrane), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0045859](http://purl.obolibrary.org/obo/GO_0045859) (regulation of protein kinase activity), [GO:0060271](http://purl.obolibrary.org/obo/GO_0060271) (cilium assembly), [GO:0009880](http://purl.obolibrary.org/obo/GO_0009880) (embryonic pattern specification), [GO:0005682](http://purl.obolibrary.org/obo/GO_0005682) (U5 snRNP), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:0005681](http://purl.obolibrary.org/obo/GO_0005681) (spliceosomal complex), [GO:0090140](http://purl.obolibrary.org/obo/GO_0090140) (regulation of mitochondrial fission), [GO:0042102](http://purl.obolibrary.org/obo/GO_0042102) (positive regulation of T cell proliferation), [GO:0000388](http://purl.obolibrary.org/obo/GO_0000388) (spliceosome conformational change to release U4 (or U4atac) and U1 (or U11)), [GO:0004115](http://purl.obolibrary.org/obo/GO_0004115) (3',5'-cyclic-AMP phosphodiesterase activity), [GO:0004114](http://purl.obolibrary.org/obo/GO_0004114) (3',5'-cyclic-nucleotide phosphodiesterase activity), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0003899](http://purl.obolibrary.org/obo/GO_0003899) (DNA-directed 5'-3' RNA polymerase activity), [GO:0042073](http://purl.obolibrary.org/obo/GO_0042073) (intraciliary transport), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0003416](http://purl.obolibrary.org/obo/GO_0003416) (endochondral bone growth), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0005891](http://purl.obolibrary.org/obo/GO_0005891) (voltage-gated calcium channel complex), [GO:0006221](http://purl.obolibrary.org/obo/GO_0006221) (pyrimidine nucleotide biosynthetic process), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0097271](http://purl.obolibrary.org/obo/GO_0097271) (protein localization to bud neck), [GO:0005930](http://purl.obolibrary.org/obo/GO_0005930) (axoneme), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0097542](http://purl.obolibrary.org/obo/GO_0097542) (ciliary tip), [GO:0001054](http://purl.obolibrary.org/obo/GO_0001054) (RNA polymerase I activity), [GO:0097546](http://purl.obolibrary.org/obo/GO_0097546) (ciliary base), [GO:0005929](http://purl.obolibrary.org/obo/GO_0005929) (cilium), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0008081](http://purl.obolibrary.org/obo/GO_0008081) (phosphoric diester hydrolase activity), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0000244](http://purl.obolibrary.org/obo/GO_0000244) (spliceosomal tri-snRNP complex assembly), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0045880](http://purl.obolibrary.org/obo/GO_0045880) (positive regulation of smoothened signaling pathway), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030552](http://purl.obolibrary.org/obo/GO_0030552) (cAMP binding), [GO:0071901](http://purl.obolibrary.org/obo/GO_0071901) (negative regulation of protein serine/threonine kinase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0035720](http://purl.obolibrary.org/obo/GO_0035720) (intraciliary anterograde transport), [GO:0030435](http://purl.obolibrary.org/obo/GO_0030435) (sporulation resulting in formation of a cellular spore), [GO:0035721](http://purl.obolibrary.org/obo/GO_0035721) (intraciliary retrograde transport), [GO:0019933](http://purl.obolibrary.org/obo/GO_0019933) (cAMP-mediated signaling), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 54.14%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 51.19%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 36.55%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005188](http://purl.obolibrary.org/obo/GO_0005188) (obsolete larval serum protein (sensu Insecta)) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.55%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005187](http://purl.obolibrary.org/obo/GO_0005187) (obsolete storage protein) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.55%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005182](http://purl.obolibrary.org/obo/GO_0005182) (obsolete lipopeptide hormone) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.55%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005181](http://purl.obolibrary.org/obo/GO_0005181) (obsolete glycopeptide hormone) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.55%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005180](http://purl.obolibrary.org/obo/GO_0005180) (obsolete peptide hormone) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.55%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005177](http://purl.obolibrary.org/obo/GO_0005177) (obsolete neuroligin) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.55%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005162](http://purl.obolibrary.org/obo/GO_0005162) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.55%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005156](http://purl.obolibrary.org/obo/GO_0005156) (obsolete epidermal growth factor receptor inhibiting ligand activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.55%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005155](http://purl.obolibrary.org/obo/GO_0005155) (obsolete epidermal growth factor receptor activating ligand activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.55%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005120](http://purl.obolibrary.org/obo/GO_0005120) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.55%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005116](http://purl.obolibrary.org/obo/GO_0005116) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.55%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005108](http://purl.obolibrary.org/obo/GO_0005108) (obsolete transmembrane ephrin) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 36.55%


